159 related articles for article (PubMed ID: 23057579)
1. The frequency of cerebral microbleeds increases with CHADS(2) scores in stroke patients with non-valvular atrial fibrillation.
Song TJ; Kim J; Lee HS; Nam CM; Nam HS; Heo JH; Kim YD
Eur J Neurol; 2013 Mar; 20(3):502-508. PubMed ID: 23057579
[TBL] [Abstract][Full Text] [Related]
2. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.
Cha MJ; Kim YD; Nam HS; Kim J; Lee DH; Heo JH
Eur J Neurol; 2012 Mar; 19(3):473-9. PubMed ID: 21972975
[TBL] [Abstract][Full Text] [Related]
3. Risk of intracerebral haemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC-Warfarin study.
Soo Y; Abrigo JM; Leung KT; Tsang SF; Ip HL; Ma SH; Ma K; Fong WC; Li SH; Li R; Ng PW; Wong KK; Liu W; Lam BYK; Wong KSL; Mok V; Chu WCW; Leung TW;
J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):428-435. PubMed ID: 30554138
[TBL] [Abstract][Full Text] [Related]
4. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
Mason PK; Lake DE; DiMarco JP; Ferguson JD; Mangrum JM; Bilchick K; Moorman LP; Moorman JR
Am J Med; 2012 Jun; 125(6):603.e1-6. PubMed ID: 22502952
[TBL] [Abstract][Full Text] [Related]
5. Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation.
Hong HJ; Kim YD; Cha MJ; Kim J; Lee DH; Lee HS; Nam CM; Nam HS; Heo JH
Eur J Neurol; 2012 Feb; 19(2):284-90. PubMed ID: 21914056
[TBL] [Abstract][Full Text] [Related]
6. Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.
Giralt-Steinhauer E; Cuadrado-Godia E; Ois A; Jiménez-Conde J; Rodríguez-Campello Á; Soriano C; Roquer J
Eur J Neurol; 2013 Apr; 20(4):623-8. PubMed ID: 22834861
[TBL] [Abstract][Full Text] [Related]
7. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
[TBL] [Abstract][Full Text] [Related]
8. Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema.
Charidimou A; Boulouis G; Shams S; Calvet D; Shoamanesh A;
J Neurol Sci; 2017 Jul; 378():102-109. PubMed ID: 28566143
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
Umemura T; Mashita S; Kawamura T
PLoS One; 2020; 15(9):e0238456. PubMed ID: 32941455
[TBL] [Abstract][Full Text] [Related]
10. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.
Moutzouri E; Glutz M; Abolhassani N; Feller M; Adam L; Gencer B; Del Giovane C; Bétrisey S; Paladini RE; Hennings E; Aeschbacher S; Beer JH; Moschovitis G; Seiffge D; De Marchis GM; Coslovsky M; Reichlin T; Conte G; Sinnecker T; Schwenkglenks M; Bonati LH; Kastner P; Aujesky D; Kühne M; Osswald S; Fischer U; Conen D; Rodondi N
Int J Stroke; 2023 Dec; 18(10):1219-1227. PubMed ID: 37243540
[TBL] [Abstract][Full Text] [Related]
11. CHA(2)DS(2)-VASc versus CHADS(2) for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry.
Piyaskulkaew C; Singh T; Szpunar S; Saravolatz L; Rosman H
J Thromb Thrombolysis; 2014 May; 37(4):400-3. PubMed ID: 23943340
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
Sandhu RK; Bakal JA; Ezekowitz JA; McAlister FA
Heart; 2011 Dec; 97(24):2046-50. PubMed ID: 22076011
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Risk Factors of Cerebral Microbleeds in Patients with Nonvalvular Atrial Fibrillation: An Enhanced T2*-Weighted Angiography Imaging Study.
Li Z; Cao L; Dong W; Zhang J; Wang C; He X; Huang W; Li Y; Zhao M
Eur Neurol; 2019; 81(3-4):112-119. PubMed ID: 31185466
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of cerebral microbleeds and risk of adverse outcomes in atrial fibrillation: a systematic review and meta-analysis.
Corica B; Romiti GF; Raparelli V; Cangemi R; Basili S; Proietti M
Europace; 2022 Oct; 24(9):1395-1403. PubMed ID: 35244694
[TBL] [Abstract][Full Text] [Related]
15. Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2) , CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measures.
Palm F; Kleemann T; Dos Santos M; Urbanek C; Buggle F; Safer A; Hennerici MG; Becher H; Zahn R; Grau AJ
Eur J Neurol; 2013 Jan; 20(1):117-23. PubMed ID: 22788384
[TBL] [Abstract][Full Text] [Related]
16. CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.
Wasmer K; Köbe J; Dechering D; Milberg P; Pott C; Vogler J; Stypmann J; Waltenberger J; Mönnig G; Breithardt G; Eckardt L
Clin Res Cardiol; 2013 Feb; 102(2):139-44. PubMed ID: 22983022
[TBL] [Abstract][Full Text] [Related]
17. The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke.
Deguchi I; Hayashi T; Ohe Y; Kato Y; Nagoya H; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e343-6. PubMed ID: 23523201
[TBL] [Abstract][Full Text] [Related]
18. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
Coppens M; Eikelboom JW; Hart RG; Yusuf S; Lip GY; Dorian P; Shestakovska O; Connolly SJ
Eur Heart J; 2013 Jan; 34(3):170-6. PubMed ID: 23018151
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Lopes RD; Al-Khatib SM; Wallentin L; Yang H; Ansell J; Bahit MC; De Caterina R; Dorian P; Easton JD; Erol C; Ezekowitz JA; Gersh BJ; Granger CB; Hohnloser SH; Horowitz J; Hylek EM; McMurray JJ; Mohan P; Vinereanu D; Alexander JH
Lancet; 2012 Nov; 380(9855):1749-58. PubMed ID: 23036896
[TBL] [Abstract][Full Text] [Related]
20. [Chinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillation].
Sun Y; Hu D; ;
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):846-50. PubMed ID: 25549561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
